Literature DB >> 24675284

Epigenetics: a new way to look at kidney diseases.

Pazit Beckerman1, Yi-An Ko1, Katalin Susztak1.   

Abstract

Only a few percent of the 3 billion pairs of chemical letters in the human genome is responsible for protein-coding sequences. Recent advances in the field of epigenomics have helped us to understand how most of the remaining sequences are responsible for gene regulation at baseline and in disease conditions. Here we discuss recent advances in the area of epigenetics--specifically in cytosine modifications--and its application in the field of nephrology.
© The Author 2014. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Keywords:  chronic kidney disease; cytosine methylation; enhancers; epigenetics

Mesh:

Year:  2014        PMID: 24675284      PMCID: PMC4173816          DOI: 10.1093/ndt/gfu026

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  45 in total

1.  TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity.

Authors:  Kristine Williams; Jesper Christensen; Marianne Terndrup Pedersen; Jens V Johansen; Paul A C Cloos; Juri Rappsilber; Kristian Helin
Journal:  Nature       Date:  2011-04-13       Impact factor: 49.962

Review 2.  Fine tuning gene expression: the epigenome.

Authors:  Davoud Mohtat; Katalin Susztak
Journal:  Semin Nephrol       Date:  2010-09       Impact factor: 5.299

3.  mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice.

Authors:  Ken Inoki; Hiroyuki Mori; Junying Wang; Tsukasa Suzuki; SungKi Hong; Sei Yoshida; Simone M Blattner; Tsuneo Ikenoue; Markus A Rüegg; Michael N Hall; David J Kwiatkowski; Maria P Rastaldi; Tobias B Huber; Matthias Kretzler; Lawrence B Holzman; Roger C Wiggins; Kun-Liang Guan
Journal:  J Clin Invest       Date:  2011-05-23       Impact factor: 14.808

4.  DNA methylation profiling identifies epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy.

Authors:  Carmen Sapienza; Jean Lee; Jasmine Powell; Oluwatoyin Erinle; Faahud Yafai; James Reichert; Elias S Siraj; Michael Madaio
Journal:  Epigenetics       Date:  2011-01-01       Impact factor: 4.528

5.  Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.

Authors:  Ian H de Boer; Tessa C Rue; Patricia A Cleary; John M Lachin; Mark E Molitch; Michael W Steffes; Wanjie Sun; Bernard Zinman; John D Brunzell; Neil H White; Ronald P Danis; Matthew D Davis; Dean Hainsworth; Larry D Hubbard; David M Nathan
Journal:  Arch Intern Med       Date:  2011-03-14

6.  Methylation determines fibroblast activation and fibrogenesis in the kidney.

Authors:  Wibke Bechtel; Scott McGoohan; Elisabeth M Zeisberg; Gerhard A Müller; Hubert Kalbacher; David J Salant; Claudia A Müller; Raghu Kalluri; Michael Zeisberg
Journal:  Nat Med       Date:  2010-04-25       Impact factor: 53.440

7.  ChIP-seq accurately predicts tissue-specific activity of enhancers.

Authors:  Axel Visel; Matthew J Blow; Zirong Li; Tao Zhang; Jennifer A Akiyama; Amy Holt; Ingrid Plajzer-Frick; Malak Shoukry; Crystal Wright; Feng Chen; Veena Afzal; Bing Ren; Edward M Rubin; Len A Pennacchio
Journal:  Nature       Date:  2009-02-12       Impact factor: 49.962

8.  Gestational choline supply regulates methylation of histone H3, expression of histone methyltransferases G9a (Kmt1c) and Suv39h1 (Kmt1a), and DNA methylation of their genes in rat fetal liver and brain.

Authors:  Jessica M Davison; Tiffany J Mellott; Vesela P Kovacheva; Jan Krzysztof Blusztajn
Journal:  J Biol Chem       Date:  2008-11-10       Impact factor: 5.157

9.  Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2.

Authors:  Myunggon Ko; Yun Huang; Anna M Jankowska; Utz J Pape; Mamta Tahiliani; Hozefa S Bandukwala; Jungeun An; Edward D Lamperti; Kian Peng Koh; Rebecca Ganetzky; X Shirley Liu; L Aravind; Suneet Agarwal; Jaroslaw P Maciejewski; Anjana Rao
Journal:  Nature       Date:  2010-12-09       Impact factor: 49.962

10.  Mapping and analysis of chromatin state dynamics in nine human cell types.

Authors:  Jason Ernst; Pouya Kheradpour; Tarjei S Mikkelsen; Noam Shoresh; Lucas D Ward; Charles B Epstein; Xiaolan Zhang; Li Wang; Robbyn Issner; Michael Coyne; Manching Ku; Timothy Durham; Manolis Kellis; Bradley E Bernstein
Journal:  Nature       Date:  2011-03-23       Impact factor: 49.962

View more
  28 in total

1.  Epigenetics and Epigenomics: Implications for Diabetes and Obesity.

Authors:  Evan D Rosen; Klaus H Kaestner; Rama Natarajan; Mary-Elizabeth Patti; Richard Sallari; Maike Sander; Katalin Susztak
Journal:  Diabetes       Date:  2018-10       Impact factor: 9.461

Review 2.  The nephrologist of tomorrow: towards a kidney-omic future.

Authors:  Mina H Hanna; Alessandra Dalla Gassa; Gert Mayer; Gianluigi Zaza; Patrick D Brophy; Loreto Gesualdo; Francesco Pesce
Journal:  Pediatr Nephrol       Date:  2016-03-09       Impact factor: 3.714

3.  Hydrogen sulfide alleviates hypertensive kidney dysfunction through an epigenetic mechanism.

Authors:  Gregory J Weber; Sathnur B Pushpakumar; Utpal Sen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-02-17       Impact factor: 4.733

4.  Systematic integrated analysis of genetic and epigenetic variation in diabetic kidney disease.

Authors:  Xin Sheng; Chengxiang Qiu; Hongbo Liu; Caroline Gluck; Jesse Y Hsu; Jiang He; Chi-Yuan Hsu; Daohang Sha; Matthew R Weir; Tamara Isakova; Dominic Raj; Hernan Rincon-Choles; Harold I Feldman; Raymond Townsend; Hongzhe Li; Katalin Susztak
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-03       Impact factor: 11.205

5.  Functional methylome analysis of human diabetic kidney disease.

Authors:  Jihwan Park; Yuting Guan; Xin Sheng; Caroline Gluck; Matthew J Seasock; A. Ari Hakimi; Chengxiang Qiu; James Pullman; Amit Verma; Hongzhe Li; Matthew Palmer; Katalin Susztak
Journal:  JCI Insight       Date:  2019-06-06

Review 6.  Molecular and Immunological Basis of Tubulo-Interstitial Injury in Lupus Nephritis: a Comprehensive Review.

Authors:  Susan Yung; Tak Mao Chan
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

Review 7.  Epigenetics: a potential key mechanism involved in the pathogenesis of cardiorenal syndromes.

Authors:  Grazia Maria Virzì; Anna Clementi; Alessandra Brocca; Massimo de Cal; Claudio Ronco
Journal:  J Nephrol       Date:  2017-08-05       Impact factor: 3.902

8.  Dnmt3a and Dnmt3b-Decommissioned Fetal Enhancers are Linked to Kidney Disease.

Authors:  Yuting Guan; Hongbo Liu; Ziyuan Ma; Szu-Yuan Li; Jihwan Park; Xin Sheng; Katalin Susztak
Journal:  J Am Soc Nephrol       Date:  2020-03-03       Impact factor: 10.121

9.  DNA hypermethylation in hyperhomocysteinemia contributes to abnormal extracellular matrix metabolism in the kidney.

Authors:  Sathnur Pushpakumar; Sourav Kundu; Nithya Narayanan; Utpal Sen
Journal:  FASEB J       Date:  2015-07-29       Impact factor: 5.191

Review 10.  Techniques and Approaches to Genetic Analyses in Nephrological Disorders.

Authors:  Laurel K Willig
Journal:  J Pediatr Genet       Date:  2015-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.